Abstract-Sodium/calcium (Na ϩ /Ca 2ϩ ) exchange (NCX) overexpression is common to human heart failure and heart failure in many animal models, but its specific contribution to the cellular Ca 2ϩ ([Ca 2ϩ ] i ) handling deficit is unclear. Here, we investigate the effects of exchange inhibitory peptide (XIP) on Ca 2ϩ handling in myocytes isolated from canine tachycardic pacing-induced failing hearts. Whole-cell patch-clamped left ventricular myocytes from failing hearts (F) showed a 52% decrease in steady-state sarcoplasmic reticulum (SR) ) handling is a key factor in the pathophysiology of heart failure. A typical failing heart cell shows a decrease in the ability of the internal stores (the sarcoplasmic reticulum [SR]) to load with Ca 2ϩ , and an increase in Ca 2ϩ extrusion from the cell by the sodium/ calcium exchanger (NCX). NCX overexpression is a component of altered Ca 2ϩ handling in human 1 and animal models, 2,3 but it is unclear whether it is compensatory or contributes to dysfunction. One widely held hypothesis is that NCX overexpression compensates for decreased Ca 2ϩ reuptake into the SR by increasing Ca 2ϩ extrusion from the cell, 4,5 which improves relaxation (positive lusitropic) but at the cost of a further depletion of SR Ca 2ϩ stores (negative inotropic). Further complicating the issue is the observation that NCX overexpression is also found in hypercontractile models with no SR dysfunction. 6 We studied the effect of partially correcting the NCX overexpression (by applying an exchange inhibitory peptide [XIP]) in a canine model of heart failure. Partial inhibition of NCX normalized both SR Ca 2ϩ release and re-uptake, arguing for a critical role for NCX overexpression in the Ca 2ϩ handling deficit as well as for its potential as a therapeutic target.
A ltered calcium (Ca 2ϩ ) handling is a key factor in the pathophysiology of heart failure. A typical failing heart cell shows a decrease in the ability of the internal stores (the sarcoplasmic reticulum [SR] ) to load with Ca 2ϩ , and an increase in Ca 2ϩ extrusion from the cell by the sodium/ calcium exchanger (NCX). NCX overexpression is a component of altered Ca 2ϩ handling in human 1 and animal models, 2, 3 but it is unclear whether it is compensatory or contributes to dysfunction. One widely held hypothesis is that NCX overexpression compensates for decreased Ca 2ϩ reuptake into the SR by increasing Ca 2ϩ extrusion from the cell, 4, 5 which improves relaxation (positive lusitropic) but at the cost of a further depletion of SR Ca 2ϩ stores (negative inotropic). Further complicating the issue is the observation that NCX overexpression is also found in hypercontractile models with no SR dysfunction. 6 We studied the effect of partially correcting the NCX overexpression (by applying an exchange inhibitory peptide [XIP] ) in a canine model of heart failure. Partial inhibition of NCX normalized both SR Ca 2ϩ release and re-uptake, arguing for a critical role for NCX overexpression in the Ca 2ϩ handling deficit as well as for its potential as a therapeutic target.
Materials and Methods
These experiments were performed using a canine tachycardic pacing-induced heart failure model. We, 2, 7, 8 and others, 9 have previously demonstrated that this animal model reproduces a remarkable number of features of the human disease. Induction of heart failure, isolation of midmyocardial cardiomyocytes, single-cell electrophysiology studies, and Ca 2ϩ measurements were performed (at 37°C) as previously described, 2 and as summarized in the expanded Methods section in the online data supplement available at http://circres.ahajournals.org.
Excitation-Contraction Coupling Experiments
The main experimental protocol (Figures 1 through 5 ) consisted of a train of 0.5-second depolarizations from Ϫ80mV to ϩ10mV, applied at 0.5 Hz until steady-state, followed by a rapid application of caffeine to measure SR Ca 2ϩ load. The external solution contained (mmol/L): NaCl 140; KCl 4; CaCl 2 2; MgCl 2 1, HEPES 5; Glucose 10; niflumic acid 0.1 (to block Ca 2ϩ -activated Cl Ϫ currents), pH 7.4. After reaching steady-state, 30 mol/L tetrodotoxin (Na ϩ channel blocker) was applied, to allow a better estimation of the peak of the L-type Ca 2ϩ current (I Ca,L ). For the experiment shown in Figure 6e through 6g, the solution had Na ϩ and Ca 2ϩ replaced with Li ϩ and Ni 2ϩ , and was K ϩ -free. Superfusing solutions were rapidly changed using a solenoid-controlled heated switching device. 2 The pipette solution contained (in mmol/L): K glutamate 125; KCl 19; MgCl 2 0.5; MgATP 5; NaCl 10; HEPES 10; pH 7.25; and 50 mol/L indo-1 (pentasodium salt, Calbiochem). The liquid junction potential between the pipette and bath was corrected post hoc.
NCX Measurement With [Ca 2؉ ] i Buffer
In Figure 6a , the NCX current was measured selectively as described previously. 2 The external solution was K ϩ -free (to block the inward rectifier K ϩ current and the Na ϩ /K ϩ pump) and also contained 100 mol/L niflumic acid, 10 mol/L strophanthidin (Na 
XIP Synthesis
XIP (RRLLFYKYVYKRYRAGKQRG) was synthesized by the Biosynthesis and Sequencing Facility, Department of Biological Chemistry, Johns Hopkins University, kept as 20 mmol/L stock in ethanol and added to the pipette solution (control experiments had equivalent amount of ethanol added, which had no effect on the parameters measured).
We did not observe any time-dependence of the effect of XIP, which reached steady-state as soon as we started recording (2 to 7 minutes from achieving the whole cell mode, at which time the indo-1 signal had reached a steady level).
Statistics shown are meanϮSEM, with PϽ0.05 as the criterion for statistical significance.
Results
Because there is currently no selective, externally applicable inhibitor of NCX (available compounds 10, 11 or inorganic blocking cations 12 are either nonselective 11, 13 or preferentially block reverse-mode exchange 10 ), we compared cellular responses in the absence and presence of exchange inhibitor peptide 14 (Figures 1 and 2 ). Internal equilibration with 10 mol/L XIP induced a large increase in the steady-state Ca SR and [Ca 2ϩ ] i transients, without any effect on I Ca,L (Figures 1 and  2) . A small increase in Ca SR was also seen in normal myocytes. At a concentration of 30 mol/L, an additional increase in ⌬Ca was observed in both groups. In failing cells, ⌬Ca was increased 3.86-fold by XIP compared with the untreated group (Figure 2c) . Importantly, and somewhat unexpectedly, the enhancement of excitation-contraction coupling occurred without a significant change in diastolic [Ca 2ϩ ] i (see later). 
Effect of XIP on [Ca 2؉ ] i Decay
Because NCX is a major Ca 2ϩ removal mechanism, especially in myocytes from failing hearts, we anticipated that XIP might decrease the rate of diastolic Ca 2ϩ decay and adversely affect cell relaxation. However, the results indicated the contrary: at steady-state, the time constant of decay of [Ca 2ϩ ] i on repolarization to the holding potential ( Ca ; representing here the combined NCX and SERCA actions) was accelerated by XIP in both groups (Figure 4a ). This indicated that NCX inhibition may be associated with an unexpected increase in the rate of SR Ca 2ϩ uptake (which was also consistent with the large increase in Ca SR ).
On closer inspection, Ca acceleration proved to be dependent not directly on XIP, but was secondary to the increase in [Ca 2ϩ ] i (Figure 4b ). In normal cells, during the development of the Ca 2ϩ staircase (as in Figure 3 ), the increase in peak [Ca 2ϩ ] i was reproducibly associated with an acceleration of Ca (Figure 4c , white circles). A similar effect was previously reported by Schouten et al 16 and attributed to SERCA activation (because it was sensitive to thapsigargin 17 ). The same relationship was found in failing cells, when the staircase was recovered in the presence of XIP (eg, Figure 4b for typical traces; Figure 4c , black circles for average data). Finally, clearly demonstrating that the acceleration of Ca i decay was not caused by XIP in itself, we could reproduce the effect in F when the [Ca 2ϩ ] i transients were enhanced by an increase in external Ca 2ϩ concentration, in the absence of XIP (Figure 4c, black diamonds) .
Therefore, we conclude that NCX inhibition, by decreasing Ca 2ϩ extrusion, induced an increase in cytosolic Ca 2ϩ i , which had the effect of stimulating SERCA. Both NCX inhibition and the indirect SERCA stimulation were responsible for the full magnitude of the inotropic effect. This occurred with the maintenance (and even improvement) of relaxation in F in the presence of XIP (see Discussion).
Quantification of NCX Inhibition
The large positive inotropic effect of 10 and 30 mol/L XIP in F required an estimation of the actual degree of NCX inhibition obtained with these concentrations.
Because NCX is the major Ca 2ϩ transporter during caffeine-induced Ca 2ϩ release, the time constant of [Ca 2ϩ ] i decay ( Ca ) in the presence of caffeine is a measure of NCX activity (Figure 1) . However, we were unable to show a significant effect on Ca for caffeine-induced Ca 2ϩ transients with 30 mol/L XIP (Figure 5a ). An alternative measure of NCX activity in these experiments is the amplitude of the inward NCX current, plotted as a function of [Ca 2ϩ ] i . This relation was also not significantly reduced by 30 mol/L XIP in either group (Figure 5b ; n values: N, 5/6; N ϩ30XIP, 9/5; F, 4/3; F ϩ30XIP, 3/3; failing group data not shown). Because XIP has been demonstrated to be an effective NCX inhibitor under various conditions, 12, 14, 15 we hypothesized that the specific conditions associated with the caffeine experiments may have masked the inhibitory effect (see Discussion). Therefore, we persisted in investigating this question by performing 2 additional experiments.
In the first, we measured NCX activity as the Ni 2ϩ -sensitive current elicited by depolarizations from Ϫ40mV to various potentials (as described 2 ). Consistent with previous results, 12 in these conditions, 30 mol/L XIP inhibited NCX by Ϸ67% (at ϩ80mV, Figure 6a and 6b) in both N and F, and the block was mode-independent.
We also estimated the degree of NCX inhibition in the minimally Ca 2ϩ -buffered conditions that were used for the excitation-contraction coupling experiments shown in Figures 1 (Figure 6c and 6d) . Under these conditions, 10 and 30 mol/L XIP induced 23% and 27% NCX inhibition, respectively (Figure 6c and 6d) .
Selectivity of NCX Inhibition
XIP has been reported to inhibit both the sarcolemmal and SR Ca 2ϩ pumps in vitro. 18 Therefore, it was important to establish that reversal of the failing phenotype was caused by a selective effect on NCX. In the same experimental conditions as for Figures 1 through 5 , the time constants of [Ca 2ϩ ] i decay attributable to the SR Ca 2ϩ pump and other, slower, mechanisms (including the plasmalemmal Ca 2ϩ ATPase, PMCA, and mitochondrial Ca 2ϩ uptake) were assessed using caffeine applications in Na ϩ -free and Ca 2ϩ -free solution 19 (see Figure  6) ; 30 mol/L XIP did not inhibit either transporter (Figure  6e and 6g) . The previously reported sensitivity of the pumps to XIP was not observed here, likely because of differences in the experimental conditions. For example, Enyedi et al 18 measured PMCA and SERCA in isolated membrane vesicles from rabbit erythrocyte and skeletal muscle preparations, respectively, and after proteolytic activation of PMCA.
Modulation by the Membrane Potential
The present experiments were designed to assess Ca 2ϩ -induced Ca 2ϩ release at the maximum Ca 2ϩ current (I Ca,L ) amplitude. However, an action potential-driven Ca i transient would likely include a component of Ca 2ϩ entry through the NCX, which is larger in F than in N. 20, 21 Therefore, it was of interest to determine if the positive inotropic effect of XIP was also evident in F during trains of action potentials in current clamp conditions. Figure 7a and 7b show that action potential-triggered Ca 2ϩ transients in F were significantly smaller than in N, and were significantly increased by 30 mol/L XIP. In N, 30 mol/L XIP also tended to increase 
Modulation by Pacing Frequency
Increased pacing frequencies are usually associated with an increase in diastolic [Ca 2ϩ ], because of the decrease in the diastolic interval; therefore, we tested whether NCX inhibition might exacerbate this increase. Figure 7c confirms that this was not the case. F groups treated with 30 mol/L XIP (nϭ4/2) had similar diastolic [Ca 2ϩ ] i levels, as compared with untreated N (nϭ5/2) when stimulated at frequencies between 0.5 and 3Hz. The increase in steady-state peak systolic [Ca 2ϩ ] i was maximal between 1 and 2 Hz.
Discussion

Effect of NCX Inhibition in Normal Canine Cells
To maintain Ca 2ϩ balance at steady-state, cellular Ca 2ϩ extrusion via forward-mode NCX must match Ca 2ϩ entry via I Ca,L and reverse-mode NCX. 22 It follows that, for the whole cardiac cycle, the net effect of NCX must be Ca 2ϩ removal (ie, forward-mode NCX must be larger than reverse-mode NCX), and partial inhibition of NCX must lead to cellular Ca 2ϩ accumulation unless Ca 2ϩ influx also declines in parallel. The increase in SR Ca 2ϩ load and the subsequent increase in the amplitude of the Ca 2ϩ transient has the dual effect of inhibiting Ca 2ϩ entry via Ca 2ϩ -dependent inactivation of I Ca,L (Figure 4b) 
Frequency-Dependent Acceleration of Relaxation
The absence of an increase in diastolic Ca 2ϩ with XIP was, however, notable. One would have predicted that inhibiting Ca 2ϩ extrusion would lead to slowed relaxation and an release was induced with caffeine. Conditioning pulse protocols were adjusted so that the size of the SR Ca 2ϩ release was similar in all 4 experimental groups. During caffeine application, the only effective Ca 2ϩ extrusion mechanisms are the plasmalemmal Ca 2ϩ ATPase (PMCA) and mitochondrial Ca 2ϩ uptake, whereas after caffeine removal, the SR Ca 2ϩ pump also contributes to Ca 2ϩ removal. 19 The time constants of Ca i decay corresponding to PMCA and mitochondrial transport and SERCA were not changed in the presence of 30 mol/L XIP. e, Caffeine-evoked Ca 2ϩ transients, in N untreated and with 30 mol/L XIP. f and g, Average data (nϭ8/4 and 6/2 for N and 9/2 and 7/2 for F, in control and with 30 mol/L XIP, respectively; PϭNS). Under control conditions, Ca corresponding to SERCA was significantly slower in F (#PϽ0.05), as expected.
increase in diastolic steady-state [Ca 2ϩ ] i . This was, a priori, an argument against the use of NCX inhibitors in heart failure. Serendipitously, we observed the opposite effect, as a consequence of indirect [Ca 2ϩ ] i -dependent stimulation of SR Ca 2ϩ uptake. Ca 2ϩ -mediated SERCA activation was first described by Schouten in 1990 16 and later coined "frequency-dependent acceleration of relaxation." 23 Although partial acceleration of SR Ca 2ϩ uptake at high Ca 2ϩ is expected because of the sigmoidal dependence of the transport kinetics on the concentration of the substrate, 17 an additional activation has been ascribed to an allosteric regulatory mechanism. The nature of the [Ca 2ϩ ] i -sensitive mediator is still unclear: a possible mechanism suggested by some, 17 but not all, 24 studies was calmodulin-dependent phosphorylation. Regardless of the mechanistic details, [Ca 2ϩ ] i -mediated SERCA activation represents an effective autoregulatory mechanism that protects against cytosolic [Ca 2ϩ ] i overload. It is also a positive feedback mechanism in which increased SR Ca 2ϩ release and uptake potentiate each other, a likely explanation for the large inotropic effect induced by a relatively modest (23% to 27%) degree of NCX block in both N and F. Frequency-dependent acceleration of relaxation has been shown to function in the failing hearts 25 and may represent an attractive inotropic target by itself.
Effect of XIP in Failing Heart Cells
Because the balance between Ca 2ϩ removal mechanisms is shifted toward more NCX-mediated Ca 2ϩ extrusion in myocytes from failing hearts, 8 one would expect that the same degree of NCX block would induce a more substantial increase in the [Ca 2ϩ ] i transients of this group. This was exactly what we observed: a 27% inhibition of the NCX (which, in failing cells, is enhanced to Ϸ200% of normal 2 ) induced a 3.86-fold increase in the [Ca 2ϩ ] i transient amplitude (Figure 2c) . Importantly, despite impaired basal SERCA function, the myocytes from failing hearts were able to autoregulate [Ca 2ϩ ] i in response to NCX inhibition by taking up and releasing more SR Ca 2ϩ . Turning this argument around, one may speculate that the substantially lower (Ϸ50% of normal) basal SR Ca 2ϩ uptake rate in heart failure 8 ( Figure 6f ), with only a 28% downregulation of pump protein, 8 may be partially caused by the lower amplitude Ca 2ϩ transients and the lack of Ca 2ϩ stimulation. There may be a vicious cycle between decreased SR Ca 2ϩ release and uptake in heart failure, which was interrupted by XIP. Analogously, the robust stimulation of SERCA activity by ␤-adrenergic stimulation in failing myocytes 8 implies a low basal SERCA activity, but sufficient recruitable reserve capacity. The present findings motivate renewed efforts toward identifying the messenger involved in the Ca 2ϩ -dependent stimulation of SERCA to clarify its therapeutic potential in heart failure.
Experimental Assumptions and Limitations
The model used here has historically generated many insights into the physiopathology of heart failure. 9 From the point of view of cellular Ca 2ϩ handling, canine (as well as rabbit and guinea pig) myocytes resemble human cells, with 70% reliance on SERCA for Ca 2ϩ decay, and 25% on NCX. This differs from small rodent species, such as rats and mice, in which NCX plays a lesser role. 26 Hence, the effect of XIP may be substantially different in these animal models. The pacing-induced heart failure model resembles the human failing phenotype, with unchanged I Ca,L , increased NCX, and decreased SERCA. One difference, however, is that we have not observed an elevation of the diastolic levels of [Ca 2ϩ ] i in F versus N, which may be true in humans with end-stage heart failure. Therefore, one must be cautious about extrapolating the results to the human disease without further investigation.
The substantial increase in the [Ca 2ϩ ] i transient in F suggested that XIP had a significant effect in these cells, but the caffeine-induced Ca 2ϩ responses retained fast [Ca 2ϩ ] i decay kinetics and large inward NCX currents (Figure 1c and  1d) . This apparent inconsistency begged the question of how much NCX was inhibited in these experiments. With alternative methods, we found that 30 mol/L XIP inhibited NCX by 67% when Ca 2ϩ was buffered to 112 nmol/L, and 27% when Ca 2ϩ was allowed to oscillate freely between Ϸ300 and 500 nmol/L, suggesting that the apparent lack of effect of XIP in the presence of caffeine could be caused by the very high intracellular free Ca 2ϩ concentrations reducing the effectiveness of the inhibitor. An alternative possibility is that the caffeine itself could be altering the extent of XIP block of the Na ϩ /Ca 2ϩ exchanger, either directly or indirectly (eg, through its inhibition of phosphodiesterase activity). With respect to the notion that XIP inhibition could be diminished at high [Ca 2ϩ ] i , it may be noted that the allosteric Ca 2ϩ binding sites and putative XIP interaction domains lie near each other on the large intracellular loop region of NCX, 27 although competition between Ca 2ϩ and XIP has not been observed in more isolated assay systems. 14 Thus, further studies will be required to validate this hypothesis. If it proves true, however, this effect would constitute an additional safeguard against XIP inducing Ca 2ϩ overload by excessive inhibition of Na ϩ /Ca 2ϩ exchange. Another important issue is that the overall contribution of NCX to Ca 2ϩ handling, and the effect of XIP documented here, is likely to be modulated by a number of cellular parameters in vivo. One is the specific contribution to the cellular Ca i transients of Ca 2ϩ entry via reverse-mode NCX during the action potential. The overall effect of NCX inhibition would represent the balance between an increase in SR Ca 2ϩ release and a decrease in NCX mediated Ca 2ϩ entry. Ca 2ϩ entry through NCX is relatively more important in F 20 , so this effect may account for the somewhat smaller (but still significant) effect of XIP on Ca 2ϩ transients evoked by action potentials versus those evoked by voltage-clamp pulses. A second consideration is that intracellular Na ϩ levels have been reported to be increased in failing hearts, 28 and this may have an impact on the effects of NCX inhibition in vivo, when Na ϩ i is not controlled by the experimental conditions.
Therapeutic Relevance
The present findings suggest that NCX inhibitors may represent a new class of positive inotropic drugs in the treatment of congestive heart failure. Even in the absence of novel drug development, improvements in gene transfer technology in the near future may make myocyte-targeted XIP expression a feasible therapy. For the goals of this study, the NCX inhibitor was selective and mode-independent, but the positive inotropic effect could, theoretically, be facilitated by a preponderantly forward-mode NCX inhibitor and/or by block of PMCA (a lesser component of total Ca 2ϩ efflux). For clinical use, other possible effects of NCX inhibitors (on arrythmogenesis, ischemia-reperfusion injury, etc) are in need of further investigation. While this is beyond the scope of the present article, it is worth noting that NCX inhibition will have both direct and indirect (ie, via the increase in Ca SR ) effects, which sometimes may be contradictory. One example is the pro-arrhythmic mechanism involving delayed afterdepolarizations. Increased Ca SR (for example, in response to sympathetic overdrive) may predispose the heart to spontaneous SR Ca 2ϩ release events, and trigger delayed afterdepolarizations as a result of forward-mode NCX current. 29 In this case, NCX inhibition would be protective by decreasing the peak amplitude of the transient inward (I ti ) current evoked by a spontaneous Ca 2ϩ release. A similar point can be made about the effect of NCX inhibition on the action potential duration (another pro-arrhythmogenic mechanism). While XIP increased the duration of the action potential for stimuli evoking a similarly-sized [Ca 2ϩ ] i transient, 30 the XIP-induced enhancement of SR Ca 2ϩ release shortens the action potential at steady-state, as a consequence of Ca 2ϩ feedback on the action potential waveform. A protective effect against ischemia-reperfusion injury would also be expected in the presence of an NCX inhibitor. 31 In summary, the present results argue that partial inhibition of NCX is a powerful method for restoring excitationcontraction coupling in heart failure. This effect is brought about by an improvement of SR Ca 2ϩ load and facilitation of the pulse-dependent positive Ca 2ϩ staircase caused by a reduction in the amount of Ca 2ϩ "stolen" from the cell on each beat by NCX. Secondary Ca 2ϩ -dependent stimulation of the SR Ca 2ϩ ATPase rate plays an additional important role in preventing diastolic [Ca 2ϩ ] i overload. This study identifies NCX inhibition as a potential therapeutic strategy in congestive heart failure, a disease in which no effective long-term treatment is available, and offers a platform for the development of a new class of positive inotropic drugs. Finally, this study uncovers the importance of SR Ca 2ϩ ATPase activation by [Ca 2ϩ ] i , whose recruitment acts synergistically with NCX block to increase both Ca 2ϩ release and removal, normalizing both sides of the contractile deficit in heart failure.
